Prelude Capital Management, LLC Innoviva, Inc. Transaction History

Prelude Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $11,308 - $15,818	-1,100 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $11,055 - $16,005	1,100 New	1,100 $12,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $18,946 - $27,763	-1,384 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $19,320 - $25,271	1,384 New	1,384 $24,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.